A court has delivered a loss for Germany-based B. Braun Melsungen, dismissing its allegations that US-based device manufacturer Becton Dickinson infringed three of its intravenous catheter patents and ruling the patents invalid.
Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which have accused Neurim of attempting to gain an unfair advantage by delaying the amendment bid until now.
Italian meat producer A.I.A. has lost its opposition to a trade mark application by competing salumi manufacturer Borgo, with the Registrar of Trade marks finding commonplace geometrical forms in trade marks that also feature a distinctive word are insufficient to distinguish a mark.
A software-implemented business method could be patentable if programmed into a computer with “some ingenuity”, IP Australia told the Full Federal Court as a landmark appeal between rival tech companies Encompass and Infotrack wrapped up Friday.
Fintech company Encompass has asked the Full Federal Court to take a more “nuanced” approach to software patentability than the one currently held by IP Australia, on the first day of a high-stakes appeal over the patentability of computer-related inventions.
The Federal Court will hear a dispute between Fueltrac and the State of Queensland over the copyright for the fuel data reporting company’s monthly pump price report.
Shenzen-based radio manufacturer Hytera Communications has lost a bid to circumvent its discovery obligations in an ongoing patent dispute with Motorola, with a Federal Court judge rejecting its claims that supplying the documents could breach Chinese state secret and cybersecurity laws.
A group representing Australian winemakers has lost its objection to the European Commission’s plan to register ‘Avola’ as a mark of geographical indication for wine.
The Commonwealth of Australia is weighing a bid to strike out Otsuka Pharmaceutical’s defence as the government seeks lost subsidies after an almost seven-year long patent dispute over the antipsychotic drug, Abilify.
An education provider calling itself Trinity College Australia faces a lawsuit alleging it is duping consumers by trying to pass off as The University of Melbourne’s famed residential college.